WordNet

building where the business of a government department is transacted
the work of a minister of religion; "he is studying for the ministry"
a government department under the direction of a minister
religious ministers collectively (especially Presbyterian)
a healthy state of wellbeing free from disease; "physicians should be held responsible for the health of their patients" (同)wellness
the general condition of body and mind; "his delicate health"; "in poor health"

PrepTutorEJDIC

《所有・所属》…『の』,…のものである,…に属する・《材料・要素》…『でできた』,から成る・《部分》…『の』[『中の』] ・《数量・単位・種類を表す名詞に付いて》…の・《原因・動機》…『で』,のために(because of) ・《主格関係》…『の』,による,によって・《目的格関係》…『を』,の・《同格関係》…『という』・《関係・関連》…『についての』[『の』],の点で・《抽象名詞などと共に》…の[性質をもつ] ・《『It is』+『形』+『of』+『名』+『to』 doの形で,ofの後の名詞を意味上の主語として》・《分離》…『から』・《起原・出所》…『から』[『の』](out of) ・《『名』+『of』+『a』(『an』)+『名』の形で》…のような・《『名』+『of』+『mine』(『yours, his』など独立所有格)の形で》…の…・《時》(1)《副詞句を作って》…に《形容詞句を作って》…の・《時刻》《米》…前(to,《米》before)
〈U〉《the~》牧師の職 / 《the~》《集合的に》聖職者,牧師(clergy) / 〈C〉(英国・欧州諸国・日本などの)『省』;省の建物 / 〈C〉《通例単数形で》大臣(公使)の職(任期) / 〈C〉《しばしばthe M-》『内閣』,閣僚たち
『健康』,健全 / (体の)状態,調子 / 《To one's health!》(健康を祝しての)乾杯
『幸福』,繁栄 / 『福祉』[事業],厚生[事業] / (米政府の)生活保護
OLD French古[代]フランス語

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 米国における労働衛生および環境衛生に関する問題についての情報および教材 information and educational resources for occupational and environmental health issues in the united states
2. 労働衛生および環境衛生の概要 overview of occupational and environmental health
3. 高齢者の健康維持 geriatric health maintenance
4. 患者向け健康情報リソースガイド guide to health information resources for patients
5. 里親により養育された小児の包括的健康管理 comprehensive health care for children in foster care

English Journal

Analysis of regulatory review times of new drugs in Japan: association with characteristics of new drug applications, regulatory agency, and pharmaceutical companies.

Ishibashi T, Kusama M, Sugiyama Y, Ono S.SourceGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo Office of Pharmaceutical Industry Research, Japan Pharmaceutical Manufacturers Association, Tokyo, Japan.
Journal of clinical pharmacy and therapeutics.J Clin Pharm Ther.2012 Dec;37(6):657-63. doi: 10.1111/j.1365-2710.2012.01363.x. Epub 2012 Jun 27.
What is known and Objective: Various factors have been reported to be associated with the duration of regulatory review of new drug applications (NDAs). We investigated potential links between the review times in Japan and the attributes of NDAs, the regulatory agency and pharmaceutical companies
PMID 22734557

Results from the first 30 months of national sentinel surveillance for influenza in Tanzania, 2008-2010.

Mmbaga VM, Mwasekaga MJ, Mmbuji P, Matonya M, Mwafulango A, Moshi S, Emukule G, Katz MA.SourceMinistry of Health and Social Welfare.
The Journal of infectious diseases.J Infect Dis.2012 Dec;206 Suppl 1:S80-6. doi: 10.1093/infdis/jis540.
Limited data exist on the burden of influenza in developing countries. In 2008, in order to better understand the epidemiology of influenza virus infection in Tanzania, the Tanzanian Ministry of Health and Social Welfare created a sentinel surveillance system for influenza. At 5 hospitals across the
PMID 23169977